🔎 Trials Near Me

Akèy › Maladi Entestinal Anflamatwa › Washington › Seattle

Etid klinik pou Maladi Entestinal Anflamatwa nan Seattle, WA

9 etid pou Maladi Entestinal Anflamatwa ap chèche patisipan nan sit nan ak bò kote Seattle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • University of Washington School Medicine, Seattle
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT06598943

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ap rekriteFaz 2
  • Site 004, Seattle
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

Familial Inflammatory Bowel Disease Early Risk

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Seattle Children's Hospital, Seattle
Laj 0 a 55 · Tout sèks · Mizajou Aug 28, 2026 · NCT07791862

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Ap rekriteFaz 3
  • Seattle Children's Hospital, Seattle
Laj 2 a 17 · Tout sèks · Mizajou Aug 24, 2026 · NCT05509777

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Ap rekriteFaz 4
  • Seattle Children's Hospital, Seattle
Laj 6 a 17 · Tout sèks · Mizajou May 27, 2026 · NCT05781152

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

Ap rekriteEtid obsèvasyon
  • Seattle Children's Hospital, Seattle
Laj 6 a 21 · Tout sèks · Mizajou Apr 24, 2026 · NCT06315179

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2
  • Mirador Therapeutics Selected Site, Silverdale · 17 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

Ap rekriteFaz 2
  • Liver institute Northwest, Seattle
Laj 18 a 75 · Tout sèks · Mizajou Oct 24, 2025 · NCT06699121

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

Ap rekrite
  • Seattle Children's Hospital, Seattle
Laj 8 a 21 · Tout sèks · Mizajou Jun 12, 2025 · NCT06216899

Etid Maladi Entestinal Anflamatwa nan lòt vil

Lòt etid nan Seattle

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.